ACRV
Price
$1.74
Change
-$0.03 (-1.69%)
Updated
Oct 14 closing price
Capitalization
54.73M
22 days until earnings call
Intraday Buy/Sell Signals
LXEO
Price
$8.50
Change
+$0.30 (+3.66%)
Updated
Oct 14 closing price
Capitalization
459.01M
61 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

ACRV vs LXEO

Header iconACRV vs LXEO Comparison
Open Charts ACRV vs LXEOBanner chart's image
Acrivon Therapeutics
Price$1.74
Change-$0.03 (-1.69%)
Volume$245.49K
Capitalization54.73M
Lexeo Therapeutics
Price$8.50
Change+$0.30 (+3.66%)
Volume$824.76K
Capitalization459.01M
ACRV vs LXEO Comparison Chart in %
ACRV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LXEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACRV vs. LXEO commentary
Oct 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACRV is a Hold and LXEO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 16, 2025
Stock price -- (ACRV: $1.74 vs. LXEO: $8.50)
Brand notoriety: ACRV and LXEO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACRV: 14% vs. LXEO: 100%
Market capitalization -- ACRV: $54.73M vs. LXEO: $459.01M
ACRV [@Biotechnology] is valued at $54.73M. LXEO’s [@Biotechnology] market capitalization is $459.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACRV’s FA Score shows that 1 FA rating(s) are green whileLXEO’s FA Score has 0 green FA rating(s).

  • ACRV’s FA Score: 1 green, 4 red.
  • LXEO’s FA Score: 0 green, 5 red.
According to our system of comparison, ACRV is a better buy in the long-term than LXEO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACRV’s TA Score shows that 5 TA indicator(s) are bullish while LXEO’s TA Score has 4 bullish TA indicator(s).

  • ACRV’s TA Score: 5 bullish, 4 bearish.
  • LXEO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ACRV is a better buy in the short-term than LXEO.

Price Growth

ACRV (@Biotechnology) experienced а -8.90% price change this week, while LXEO (@Biotechnology) price change was +1.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.76%. For the same industry, the average monthly price growth was +13.99%, and the average quarterly price growth was +268.92%.

Reported Earning Dates

ACRV is expected to report earnings on Nov 06, 2025.

LXEO is expected to report earnings on Dec 15, 2025.

Industries' Descriptions

@Biotechnology (+0.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LXEO($459M) has a higher market cap than ACRV($54.7M). LXEO YTD gains are higher at: 29.179 vs. ACRV (-71.096). ACRV has higher annual earnings (EBITDA): -93.21M vs. LXEO (-111.97M). ACRV (137M) and LXEO (133M) have equal amount of cash in the bank . ACRV has less debt than LXEO: ACRV (3.26M) vs LXEO (8.91M). ACRV (0) and LXEO (0) have equivalent revenues.
ACRVLXEOACRV / LXEO
Capitalization54.7M459M12%
EBITDA-93.21M-111.97M83%
Gain YTD-71.09629.179-244%
P/E RatioN/AN/A-
Revenue00-
Total Cash137M133M103%
Total Debt3.26M8.91M37%
TECHNICAL ANALYSIS
Technical Analysis
ACRVLXEO
RSI
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 8 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 8 days ago
90%
Momentum
ODDS (%)
Bullish Trend 8 days ago
77%
Bullish Trend 13 days ago
90%
MACD
ODDS (%)
Bullish Trend 8 days ago
67%
Bullish Trend 8 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 8 days ago
82%
Bullish Trend 8 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 8 days ago
88%
Bullish Trend 8 days ago
88%
Advances
ODDS (%)
Bullish Trend 13 days ago
88%
Bullish Trend 22 days ago
88%
Declines
ODDS (%)
Bearish Trend 21 days ago
88%
Bearish Trend 10 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 8 days ago
90%
Aroon
ODDS (%)
Bullish Trend 8 days ago
90%
Bullish Trend 8 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ACRV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LXEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SFPIX12.810.20
+1.59%
Saratoga Financial Services I
SIVIX17.330.24
+1.40%
State Street Instl Small-Cap Equity Inv
AFCGX19.600.02
+0.10%
American Century Focused Intl Gr G
FCSDX18.03N/A
N/A
Fidelity Advisor Strategic Div & Inc C
ICEIX24.88-0.09
-0.36%
Macquarie International Core Eq I

ACRV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACRV has been loosely correlated with ALLR. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ACRV jumps, then ALLR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACRV
1D Price
Change %
ACRV100%
-1.69%
ALLR - ACRV
46%
Loosely correlated
-0.65%
AURA - ACRV
40%
Loosely correlated
+0.49%
LXEO - ACRV
37%
Loosely correlated
+3.66%
HUMA - ACRV
37%
Loosely correlated
+1.70%
XNCR - ACRV
37%
Loosely correlated
-10.96%
More

LXEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, LXEO has been loosely correlated with TERN. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if LXEO jumps, then TERN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LXEO
1D Price
Change %
LXEO100%
+3.66%
TERN - LXEO
44%
Loosely correlated
-1.46%
SLDB - LXEO
43%
Loosely correlated
+3.66%
RGNX - LXEO
43%
Loosely correlated
-0.79%
BEAM - LXEO
42%
Loosely correlated
+0.12%
VTYX - LXEO
42%
Loosely correlated
-1.62%
More